One estimate $216M.
Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on PBYI:
- Puma Biotechnology reports Q EPS 21c, one estimate 9c
- Puma Biotechnology reports Q3 EPS 21c, one estimate 9c
- PBYI Earnings Report this Week: Is It a Buy, Ahead of Earnings?
- Puma Biotechnology’s Phase 2 Study of Alisertib: A Promising Update for Investors
- Puma Biotechnology’s Alisertib Study: A Potential Game-Changer for Small Cell Lung Cancer